Form 8-K - Current report:
SEC Accession No. 0001558370-24-001707
Filing Date
2024-02-26
Accepted
2024-02-26 16:19:43
Documents
14
Period of Report
2024-02-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K rsls-20240223x8k.htm   iXBRL 8-K 61794
  Complete submission text file 0001558370-24-001707.txt   178891

Data Files

Seq Description Document Type Size
2 EX-101.SCH rsls-20240223.xsd EX-101.SCH 3105
3 EX-101.LAB rsls-20240223_lab.xml EX-101.LAB 15240
4 EX-101.PRE rsls-20240223_pre.xml EX-101.PRE 9781
15 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20240223x8k_htm.xml XML 4674
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 24679011
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)